Clinical Trial Update: Safety Study of MultiGeneAngio in Patients With Peripheral Arterial Disease (PAD) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on the safety study of MultiGeneAngio for peripheral arterial disease, including intermittent claudication, in Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Arterial Disease

Drugs mentioned

• MultiGeneAngio

Snippet

Sponsor: MultiGene Vascular Systems Ltd. | Conditions: PAD, Claudication | Phase 1, Phase 2 | Status: UNKNOWN